HCPCS code J9350 — Inj mosunetuzumab-axgb, 1 mg. Status: Active. Effective Jul 1, 2023. Source: CMS HCPCS Level II.

J9350

Active

Inj mosunetuzumab-axgb, 1 mg

Injection, mosunetuzumab-axgb, 1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jul 1, 2023
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 9150

MUE — Medically Unlikely Edits

Maximum units of J9350 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 60
Practitioner Services 60

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
50242-0142-01 Lunsumio
50242-0159-01 Lunsumio

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2023-Q3
    Inj mosunetuzumab-axgb, 1 mg